Role of AS-OCT in Assessment of Corneal Perforation

Role of Anterior Segment Optical Coherence Tomography in Assessment of Healing of Thin or Perforated Cornea Treated by Amniotic Membrane Graft and Platelet Rich Plasma Clot

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06422897

Acronym

OCT

Enrollment

Registered

2024-05-21

Start date

2024-04-15

Completion date

2024-06-05

Last updated

2024-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Perforation

Brief summary

Assessment of healing of thin and perforated cornea after surgical treatment by anterior segment optical coherence tomography

Detailed description

* thin and perforated cornea (small perforation) is surgically treated by amniotic membrane graft and platelet rich plasma clot * anterior segment optical coherence tomography is performed preoperative and 1 month postoperative to assess healing

Interventions

OTHERanterior segment optical coherence tomography

surgically treated corneal perforation by amniotic membrane graft and platelet rich plasma clot is assessed by anterior segment optical coherence tomography 1 month postoperative

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* thin cornea about to perforate * small corneal perforation

Exclusion criteria

* active infection

Design outcomes

Primary

Measure	Time frame	Description
Depth of corneal healing measured by optical coherence tomography	1 month	complete corneal healing by anterior segment optical coherence tomography

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026